Drreddys Laboratories | RDY - 债务

金融业

INR

INR 6.26B

现金及等价物

INR 18.66B

INR 40.46B

INR 3.31B

INR 1.76B

INR 67.73B

股息收益率

INR 0.65

INR 16.37B

INR 21.59B

INR 27.81K

EPS每股收益

INR 0.06

股本和储备

INR 4.14B

INR 46.81B

债务利息支出

INR 944M

INR 796M

INR 129.19M

INR 2.24B

INR 12.1B

INR 72.94B

INR 14.33B

普通股股本

INR 832.57M

18.27

INR 15.43B

INR 789.05M

销售和管理费用

INR 26.92B

INR 79.01B

贸易债权人

INR 454.04M

应收帐款人

INR 1.41B

	债务	更改		日
ANI Pharmaceuticals	USD 617.04M		3.28M	2025-12
Aurora Cannabis	CAD 100.34M		1.29M	2025-09
Bayer	EUR 36.45B		2.93B	2025-12
Canopy Growth	CAD 259.33M		68.47M	2025-09
Cipla	INR 4.38B		231.9M	2025-03
Corcept Therapeutics	USD 6.11M		251K	2025-12
Drreddys Laboratories	INR 67.73B		19.09B	2025-12
GlaxoSmithKline	GBP 19.06B		1.34B	2026-03
Hikma Pharmaceutical	USD 1.56B		252M	2025-06
Lonza	CHF 4.71B		915M	2024-12
Novartis	USD 47B		11.62B	2026-03
Pacira	USD 367.66M		4.53M	2026-03
Phibro Animal Health	USD 474.17M		730K	2024-09
Prestige Brands	USD 1.08B		38.27M	2025-12
Richter Gedeon	HUF 21.74B		1.93B	2024-12
Sun Pharmaceuticals	INR 23.62B		2.1B	2025-03
Supernus Pharmaceuticals	USD 40.98M		1.23M	2025-12
Teva Pharmaceutical Industries	USD 17.09B		21M	2025-12